A contingent value right issued to former shareholders of NPS Pharmaceuticals following its 2015 acquisition by Shire, tied to future sales milestones for the parathyroid hormone therapy Natpara. The security trades over-the-counter and represents a potential payout if specified revenue thresholds a...
This page tracks all publicly disclosed congressional trades in NPSND (NPSND), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 0 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-09-08 | Shelley M Capito | buy | $1K – $15K |